We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
-19.47%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$218M
AUM Growth
-$76.3M
Cap. Flow
-$14.5M
Cap. Flow %
-6.67%
Top 10 Hldgs %
65.96%
Holding
150
New
8
Increased
33
Reduced
60
Closed
28

Top Buys

Rank Stock Value
1
ARCC icon
Ares Capital
ARCC
+$2.64M
2
TRGP icon
Targa Resources
TRGP
+$1.65M
3
IBM icon
IBM
IBM
+$1.41M
4
TTI icon
TETRA Technologies
TTI
+$819K
5
BMY icon
Bristol-Myers Squibb
BMY
+$807K

Sector Composition

Rank Sector Weight
1 Financials 55.25%
2 Technology 15.54%
3 Healthcare 9.56%
4 Industrials 6.39%
5 Energy 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
1
T. Rowe Price
TROW
$25.4B
$109M 50.19%
1,119,402
-20,580
-2% -$2.52M
ENPH icon
2
Enphase Energy
ENPH
$4.89B
$6.29M 2.89%
194,665
-143,400
-42% -$5.4M
AAPL icon
3
Apple
AAPL
$4.93T
$5.49M 2.52%
86,312
-24,128
-22% -$1.77M
JNJ icon
4
Johnson & Johnson
JNJ
$646B
$3.65M 1.68%
27,852
-1,193
-4% -$169K
BMY icon
5
Bristol-Myers Squibb
BMY
$128B
$3.64M 1.67%
65,238
+13,204
+25% +$807K
MSFT icon
6
Microsoft
MSFT
$2.92T
$3.46M 1.59%
21,944
-1,948
-8% -$320K
GLW icon
7
Corning
GLW
$120B
$3.27M 1.5%
159,381
+6,025
+4% +$157K
CVS icon
8
CVS Health
CVS
$137B
$2.93M 1.35%
49,414
+4,145
+9% +$277K
GSK icon
9
GSK
GSK
$104B
$2.86M 1.31%
60,310
-196
-0.3% -$10.5K
IBM icon
10
IBM
IBM
$205B
$2.78M 1.28%
26,240
+11,170
+74% +$1.41M
ACA icon
11
Arcosa
ACA
$7.13B
$2.78M 1.28%
69,935
-2,560
-4% -$108K
QCOM icon
12
Qualcomm
QCOM
$178B
$2.6M 1.19%
38,448
+118
+0.3% +$9.67K
ABB
13
DELISTED
ABB Ltd
ABB
$2.27M 1.04%
131,750
-7,237
-5% -$158K
EGIO
14
DELISTED
Edgio, Inc. Common Stock
EGIO
$2.22M 1.02%
9,723
-177
-2% -$35.2K
NOK icon
15
Nokia
NOK
$50.2B
$2.11M 0.97%
679,850
+3,600
+0.5% +$13.4K
BRK.B icon
16
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.1M 0.97%
11,518
+190
+2% +$40.4K
ABBV icon
17
AbbVie
ABBV
$457B
$2.07M 0.95%
27,136
+1,035
+4% +$88.2K
MDC
18
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.92M 0.88%
89,357
-4,804
-5% -$168K
ZYME icon
19
Zymeworks
ZYME
$1.71B
$1.73M 0.79%
48,660
-650
-1% -$26.6K
ARCC icon
20
Ares Capital
ARCC
$13.6B
$1.69M 0.77%
+156,575
New +$2.64M
USB icon
21
US Bancorp
USB
$98.6B
$1.55M 0.71%
44,935
-200
-0.4% -$9.64K
TPIC
22
DELISTED
TPI Composites
TPIC
$1.51M 0.69%
102,055
+1,430
+1% +$28.1K
PG icon
23
Procter & Gamble
PG
$347B
$1.48M 0.68%
13,421
-75
-0.6% -$9K
KN icon
24
Knowles
KN
$3.13B
$1.44M 0.66%
107,975
-8,316
-7% -$145K
HON icon
25
Honeywell
HON
$77.2B
$1.34M 0.62%
10,645
-27
-0.3% -$4.17K

Similar funds

Marathon Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Marathon Capital Management held 150 positions worth $218M, down 26% from $294M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Marathon Capital Management withdrew a net $14.5M in Q1 2020, closing 28 positions and reducing 60 holdings. Its most notable exit was Air Lease Corp, an estimated $2.73M position sold in full.

By sector, the portfolio is most concentrated in Financials at 55% of assets, up from 52% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Marathon Capital Management opened a new position in Ares Capital worth $1.69M.

  • Marathon Capital Management's largest Q1 2020 buy was Ares Capital: 156,575 shares worth $1.69M.
  • Marathon Capital Management added most to Targa Resources in Q1 2020, an estimated $1.65M increase.
  • Marathon Capital Management's biggest Q1 2020 reduction was Enphase Energy, cutting an estimated $5.4M.
  • Marathon Capital Management fully exited Air Lease Corp in Q1 2020, selling an estimated $2.73M.
  • Marathon Capital Management's ten largest holdings make up 66% of its $218M portfolio in Q1 2020.
  • Marathon Capital Management opened 8 new positions and closed 28 in Q1 2020.
  • Marathon Capital Management's portfolio value fell 26% quarter-over-quarter to $218M.

Based on Marathon Capital Management's 13F filing for Q1 2020, filed 15 May 2020.